| abstract |
The present invention relates to a transdermal absorption preparation containing polmacoxib, the preparation being capable of minimizing the influence of both extrinsic and intrinsic factors and maintaining stable blood concentrations for a predetermined period of time, while maintaining characteristics, such as efficacy and effective dose, of polmacoxib. In addition, side effects, caused by the administration of the preparation, on the internal organs can be minimized and administration frequency can be reduced, and thus patient compliance can be increased. |